Skip to main content

Table 3 Treatment of incident and prevalent patients following diagnosis

From: Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry

Treatment, n

Incident (n = 91)

Prevalent (n = 100)

Calcium channel blockers

3

2

Bosentan

27

25

Sildenafil

35

31

Treprostinil

4

5

Epoprostenol

-

1

Combination therapy

11

26

  Bosentan + sildenafil

3

14

  Bosentan + iloprost

2

-

  Sildenafil + iloprost

2

2

  Sildenafil + treprostinil

2

4

  Sildenafil + epoprostenol

2

4

  Epoprostenol + sildenafil + bosentan

-

2

Investigational drugs

7

5

No specific therapy

4

5